These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4724782)

  • 21. [Therapeutic success with the Psoriacid-Stick in psoriasis].
    Schafé MK
    Z Haut Geschlechtskr; 1966 May; 40(10):347-51. PubMed ID: 5996802
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
    Ernst TM
    Z Hautkr; 1981 Sep; 56(18):1197-206. PubMed ID: 7293304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The antipsoriatic effect of cignolin in comparison (autoradiographic and histochemical) with fluocinolone acetonide].
    Kalkoff KW; Born W; Reinhard W
    Arch Klin Exp Dermatol; 1966; 227(1):857-66. PubMed ID: 5984847
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on suspension ointments. Part 2: The Diffusion of salicylic acid as influenced by the colloid chemical properties of the vehicle (author's transl)].
    Wahlgren S
    Pharmazie; 1979; 34(9):545-7. PubMed ID: 542487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reflex spectrophotometry of drugs for external use. II. Color stability of the surface of zinc-chloride paste with resorcin].
    Melichar M; Pokorná M
    Cesk Farm; 1974 Sep; 23(7):264-8. PubMed ID: 4434482
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute perceptive hearing loss and metabolic acidosis as complications of the topical treatment of psoriasis with salicylic acid-containing ointment].
    Jongevos SF; Prens EP; Wolterbeek JH; Habets JM
    Ned Tijdschr Geneeskd; 1997 Oct; 141(43):2075-9. PubMed ID: 9550768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood salicylates in children treated with ointments containing salicylic acid].
    Najbrt V
    Cesk Dermatol; 1973 Jun; 48(3):179-83. PubMed ID: 4725885
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effect of lipoperoxide and dithranol (cignolin) on psoriasis vulgaris].
    Meffert H; Reich P
    Dermatol Monatsschr; 1969; 155(3):157-61. PubMed ID: 4919704
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preliminary note on the local therapy of psoriasis with losalen].
    Marrón Gasca J; Giménez Serrano H; Calvo Morales A; Moreno Garcés F
    Actas Dermosifiliogr; 1974; 65(7-8):305-6. PubMed ID: 4455050
    [No Abstract]   [Full Text] [Related]  

  • 30. STABILITY OF BILIRUBIN.
    FOG J; BUGGE-ASPERHEIM B
    Nature; 1964 Aug; 203():756-7. PubMed ID: 14207277
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the dispersity of drugs with special reference to suspension ointments. 5. The storage stability of salicylic acid and prednisolone powders].
    Horsch W; Kögel J; Jäckel A
    Pharmazie; 1975 Jun; 30(6):371-2. PubMed ID: 1161786
    [No Abstract]   [Full Text] [Related]  

  • 32. Stability of homatropine in aqueous solution.
    Krasowska MH; Larsen SS; Ilver K
    Dan Tidsskr Farm; 1968; 42(6):170-8. PubMed ID: 5724912
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical approaches to the mode of action of carboxypeptidase A.
    Vallee BL; Riordan JF
    Brookhaven Symp Biol; 1968 Jun; 21(1):91-119. PubMed ID: 5721305
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current knowledge on the pathogenesis of common psoriasis as the basis for a scientifically founded therapy. II. Therapeutic possibilities and pathogenetic principles of antipsoriatic drugs].
    Sönnichsen N; Haustein UF; Kluge K; Meffert H
    Dtsch Gesundheitsw; 1970 Jul; 25(28):1293-300. PubMed ID: 4933541
    [No Abstract]   [Full Text] [Related]  

  • 35. [Histochemical findings in psoriasis focal areas and their immediate vicinity during healing by Cignolin treatment].
    Theune J; Wohlrab W
    Hautarzt; 1966 Oct; 17(10):463-6. PubMed ID: 5997579
    [No Abstract]   [Full Text] [Related]  

  • 36. [Duration of treatment in psoriasis using combined anthraline salicylic acid petrolatum].
    Laum JH; Steigleder GK
    Hautarzt; 1972 May; 23(5):204-6. PubMed ID: 5043822
    [No Abstract]   [Full Text] [Related]  

  • 37. Spectrophotometric investigation of changes of caffeic, chlorogenic and isochlorogenic acids under the influence of some physicochemical factors.
    Grodzińska-Zachwieja Z; Kahl W; Klimczak M
    Pol J Pharmacol Pharm; 1973; 25(3):299-305. PubMed ID: 4781486
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mast cells in skin altered by psoriasis--before, during and after cignolin therapy].
    Schmitz H
    Dermatol Wochenschr; 1967 Mar; 153(9):225-33. PubMed ID: 6082804
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psoriasis: the clinical use of "minute therapy" with Cignolin].
    Runne U; Kunze J
    Z Hautkr; 1983 Feb; 58(4):219-29. PubMed ID: 6845794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Percutaneous salicylate poisoning during psoriasis].
    Hincky M; Bourgeois-Spinasse J; Girard G; De Lara C; Grupper C
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(6):833-5. PubMed ID: 5590537
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.